Combination enzyme therapy for digestion of dietary gluten
US8778338B2 · kind B2 · utility
1Cited by
45References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2008 |
| Grant date | Jul 15, 2014 |
| Priority date | — |
| Expiry date | May 27, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P39/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A combination enzyme product consisting of a glutamine specific endoprotease and a prolyl endopeptidase is provided. Both enzymes are active and stable in the stomach and can therefore be administered as lyophilized powders or simple capsules/tablets. A ratio of the two enzymes is used to maximize their synergy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.